DexCom Inc (DXCM)vsiTonic Holdings Ltd. (ITOC)
DXCM
DexCom Inc
$75.14
+0.39%
HEALTHCARE · Cap: $29.58B
ITOC
iTonic Holdings Ltd.
$0.25
-3.47%
HEALTHCARE · Cap: $6.55M
Smart Verdict
WallStSmart Research — data-driven comparison
DexCom Inc generates 921052% more annual revenue ($4.82B vs $523,030). DXCM leads profitability with a 19.3% profit margin vs 0.0%. DXCM earns a higher WallStSmart Score of 72/100 (B).
DXCM
Strong Buy72
out of 100
Grade: B
ITOC
Avoid33
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+89.6%
Fair Value
$656.95
Current Price
$75.14
$581.81 discount
Intrinsic value data unavailable for ITOC.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Every $100 of equity generates 31 in profit
Earnings expanding 92.2% YoY
Strong operational efficiency at 21.4%
15.0% revenue growth
Reasonable price relative to book value
Revenue surging 91.6% year-over-year
Conservative balance sheet, low leverage
Areas to Watch
Premium valuation, high expectations priced in
Trading at 9.8x book value
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : DXCM
The strongest argument for DXCM centers on Return on Equity, EPS Growth, Operating Margin. Profitability is solid with margins at 19.3% and operating margin at 21.4%. Revenue growth of 15.0% demonstrates continued momentum.
Bull Case : ITOC
The strongest argument for ITOC centers on Price/Book, Revenue Growth, Debt/Equity. Revenue growth of 91.6% demonstrates continued momentum.
Bear Case : DXCM
The primary concerns for DXCM are P/E Ratio, Price/Book.
Bear Case : ITOC
The primary concerns for ITOC are EPS Growth, Market Cap, Profit Margin.
Key Dynamics to Monitor
DXCM profiles as a mature stock while ITOC is a hypergrowth play — different risk/reward profiles.
ITOC is growing revenue faster at 91.6% — sustainability is the question.
DXCM generates stronger free cash flow (449M), providing more financial flexibility.
Monitor MEDICAL DEVICES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
DXCM scores higher overall (72/100 vs 33/100), backed by strong 19.3% margins and 15.0% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
DexCom Inc
HEALTHCARE · MEDICAL DEVICES · USA
DexCom, Inc. is a company that develops, manufactures, and distributes continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with headquarters in San Diego, California, and has a manufacturing facility in Mesa, Arizona.
iTonic Holdings Ltd.
HEALTHCARE · MEDICAL DEVICES · USA
iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?